149 related articles for article (PubMed ID: 1912518)
1. Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.
Concha A; Esteban F; Cabrera T; Ruiz-Cabello F; Garrido F
Semin Cancer Biol; 1991 Feb; 2(1):47-54. PubMed ID: 1912518
[TBL] [Abstract][Full Text] [Related]
2. [Immunologic modulation of tumor aggressiveness in cancer of the larynx. II. Clinicopathologic correlations with the loss of expression of the HLA ABC antigens].
Esteban F; Concha A; Delgado M; Ruiz-Cabello F; Garrido F
Acta Otorrinolaringol Esp; 1990; 41(6):359-68. PubMed ID: 2092725
[TBL] [Abstract][Full Text] [Related]
3. [Immunologic modulation of tumor aggressiveness in cancer of the larynx. I. Genetic and molecular studies of HLA class I antigens].
Esteban F; Concha A; Ruiz-Cabello F; Garrido F
Acta Otorrinolaringol Esp; 1990; 41(5):297-303. PubMed ID: 2076309
[TBL] [Abstract][Full Text] [Related]
4. MHC expression on human tumors--its relevance for local tumor growth and metastasis.
Garrido F; Ruiz-Cabello F
Semin Cancer Biol; 1991 Feb; 2(1):3-10. PubMed ID: 1912516
[TBL] [Abstract][Full Text] [Related]
5. MHC class I antigen expression is inversely related with tumor malignancy and ras oncogene product (p21ras) levels in human breast tumors.
Solana R; Romero J; Alonso C; Peña J
Invasion Metastasis; 1992; 12(3-4):210-7. PubMed ID: 1294532
[TBL] [Abstract][Full Text] [Related]
6. HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.
Ogino T; Shigyo H; Ishii H; Katayama A; Miyokawa N; Harabuchi Y; Ferrone S
Cancer Res; 2006 Sep; 66(18):9281-9. PubMed ID: 16982773
[TBL] [Abstract][Full Text] [Related]
7. Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx.
Esteban F; Concha A; Delgado M; Pérez-Ayala M; Ruiz-Cabello F; Garrido F
Br J Cancer; 1990 Dec; 62(6):1047-51. PubMed ID: 2257212
[TBL] [Abstract][Full Text] [Related]
8. Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters.
Redondo M; Concha A; Oldiviela R; Cueto A; Gonzalez A; Garrido F; Ruiz-Cabello F
Cancer Res; 1991 Sep; 51(18):4948-54. PubMed ID: 1654207
[TBL] [Abstract][Full Text] [Related]
9. HLA molecule expression in cutaneous squamous cell carcinomas: an immunopathological study and clinical-immunohistopathological correlations.
García-Plata D; Mozos E; Carrasco L; Solana R
Histol Histopathol; 1993 Apr; 8(2):219-26. PubMed ID: 7683937
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of HLA DR expression and lymphocytic infiltrate in laryngeal cancer including clinical and morphological correlations.
Sikorska B; Danilewicz M; Wagrowska-Danilewicz M
Gen Diagn Pathol; 1998 Apr; 143(5-6):297-303. PubMed ID: 9653911
[TBL] [Abstract][Full Text] [Related]
11. MHC antigen expression in colorectal tumours.
Smith ME
Semin Cancer Biol; 1991 Feb; 2(1):17-21. PubMed ID: 1912514
[TBL] [Abstract][Full Text] [Related]
12. [Research into the human leucocyte antigen I deletion and local lymphocytes infiltration in laryngeal carcinoma].
Niu C; Liu X; Zhou W; Jing L; Du B
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Jun; 37(3):215-8. PubMed ID: 12772327
[TBL] [Abstract][Full Text] [Related]
13. Distribution of class I and II human leukocyte antigens in the larynx.
Wang EC; Damrose EJ; Mendelsohn AH; Nelson SD; Shintaku IP; Ye M; Berke GS; Blackwell KE
Otolaryngol Head Neck Surg; 2006 Feb; 134(2):280-7. PubMed ID: 16455378
[TBL] [Abstract][Full Text] [Related]
14. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas.
Cordon-Cardo C; Fuks Z; Drobnjak M; Moreno C; Eisenbach L; Feldman M
Cancer Res; 1991 Dec; 51(23 Pt 1):6372-80. PubMed ID: 1933900
[TBL] [Abstract][Full Text] [Related]
15. Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma.
Möller P; Momburg F; Koretz K; Moldenhauer G; Herfarth C; Otto HF; Hämmerling GJ; Schlag P
Cancer Res; 1991 Jan; 51(2):729-36. PubMed ID: 1985791
[TBL] [Abstract][Full Text] [Related]
16. Characterization of human prostate and breast cancer cell lines for experimental T cell-based immunotherapy.
Carlsson B; Forsberg O; Bengtsson M; Tötterman TH; Essand M
Prostate; 2007 Mar; 67(4):389-95. PubMed ID: 17219382
[TBL] [Abstract][Full Text] [Related]
17. Low prevalence of selective human leukocyte antigen (HLA)-A and HLA-B epitope losses in early-passage tumor cell lines.
Giacomini P; Giorda E; Fraioli R; Nicotra MR; Vitale N; Setini A; Delfino L; Morabito A; Benevolo M; Venturo I; Mottolese M; Ferrara GB; Natali PG
Cancer Res; 1999 Jun; 59(11):2657-67. PubMed ID: 10363989
[TBL] [Abstract][Full Text] [Related]
18. Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.
Stopeck AT; Gessner A; Miller TP; Hersh EM; Johnson CS; Cui H; Frutiger Y; Grogan TM
Clin Cancer Res; 2000 Oct; 6(10):3904-9. PubMed ID: 11051236
[TBL] [Abstract][Full Text] [Related]
19. Lack of expression of HLA-ABC antigens in choriocarcinoma and other human tumor cell lines.
Travers PJ; Arklie JL; Trowsdale J; Patillo RA; Bodmer WF
Natl Cancer Inst Monogr; 1982; 60():175-80. PubMed ID: 6181407
[TBL] [Abstract][Full Text] [Related]
20. Expression of HLA-A, -B, -C, -DR, -DP, -DQ, and of HLA-D-associated invariant chain (Ii) in non-neoplastic mammary epithelium, fibroadenoma, adenoma, and carcinoma of the breast.
Möller P; Mattfeldt T; Gross C; Schlosshauer P; Koch A; Koretz K; Moldenhauer G; Kaufmann M; Otto HF
Am J Pathol; 1989 Jul; 135(1):73-83. PubMed ID: 2549795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
